Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Arbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who decide whether treatment is appropriate. Compounded medications are prepared by licensed U.S. pharmacies for individual patients and are not reviewed by the FDA for safety or effectiveness.
Sources
- Aloraini K, et al. Glutathione for skin lightening via intravenous, oral, and topical routes: a critical narrative review. J Med Life. 2026;19(7):511-523.
- Watanabe F, et al. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women. Clin Cosmet Investig Dermatol. 2014;7:267-274.
- Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study. J Dermatolog Treat. 2012;23(2):97-102.
- Weschawalit S, et al. Glutathione and its antiaging and antimelanogenic effects. Clin Cosmet Investig Dermatol. 2017;10:147-153.
- Zubair S, Hafeez S, Mujtaba G. Efficacy of intravenous glutathione vs. placebo for skin tone lightening. J Pak Assoc Dermatol. 2016;26(3):177-181.
- Sarkar R, et al. Glutathione as a skin-lightening agent and in melasma: a systematic review. Int J Dermatol. 2025;64(6):992-1004.
- Khanna R, Rambhia P, Chapas A. Systematic review of the efficacy and safety of topical glutathione in dermatology. J Clin Aesthet Dermatol. 2025;18(9):51-54.
- Aebi S, Assereto R, Lauterburg BH. High-dose intravenous glutathione in man. Eur J Clin Invest. 1991;21(1):103-110.
- Witschi A, et al. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992;43(6):667-669.
- Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263.
- Centers for Disease Control and Prevention. Adverse events linked to injectable glutathione compounded with dietary supplement grade ingredient: current situation (September 2026).
- U.S. Food and Drug Administration. FDA reminds compounders not to use dietary supplement grade glutathione for injectables (August 27, 2026).
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.








